Articles by Michael Okonkwo
SpaceX Faces 378M Share Lockup Expiry; Trading Risk Ahead
SpaceX (SPCX) faces a 378.1M share lockup expiry this week, equal to 7.7 days of trading. Q2 revenue surged 92%, but losses persist. Analysts see 103% upside.
NSE IPO Gets SEBI Nod: Purely an Offer for Sale, No Fresh Capital
NSE's IPO has cleared SEBI's review. The offer comprises 148.9 million existing shares, with no new capital raised. All proceeds go to selling shareholders.
Deepa Jewellers IPO Oversubscribed 42.6x, But Cash Flow Concerns Loom
Deepa Jewellers' IPO was oversubscribed 42.6 times, but the company's operating cash flow remained negative despite a 158% profit surge, raising concerns.
SpaceX Stock Surges 5.6% as Valuation Hits 63x Revenue
SpaceX shares rose 5.6% to $148.61, pushing market cap to $1.96 trillion. Connectivity leads profits, while AI and capex raise concerns.
Anthropic's $175B Cloud Push Intensifies IPO Speculation
Anthropic's cloud commitments reach $175B with a new $35B Lambda deal, intensifying IPO speculation as the company cuts token prices by 25%.
SHEIN Ends First Day Flat After Sharp Intraday Drop
SHEIN shares closed nearly flat in Hong Kong debut after a 10% intraday drop, with a small float complicating price discovery.
SHEIN's Hong Kong Debut Ends Flat After Volatile First Day
SHEIN's Hong Kong IPO closed nearly flat after a volatile first day, with shares dropping 10% intraday before recovering. The debut valued the company at $26.3 billion.
SpaceX Edges Higher Despite Capex Exceeding Revenue 2.35x
SpaceX closed Friday at $141.50, up 0.45%, with Q2 revenue up 92% to $7.81B. However, capital expenditures reached $18.37B, 2.35x revenue, driven by AI infrastructure.
SpaceX Edges Up 0.5% as Louisiana Starbase's $100B Capex Plan Fuels IPO Speculation
SpaceX stock rose 0.45% to $141.50 as the company's $100B Louisiana Starbase commitment shifts focus to execution, with construction set for 2027 and first launch in 2029.
Wellchange Stock Soars 33% Despite 85% Discounted Share Sale
Wellchange shares surged 33% despite pricing a 50 million-share offering at an 85% discount, raising $7.5 million. The deal highlights investor speculation amid heavy dilution.
Exascale Labs Debuts on Nasdaq, Shares Jump 12% Despite Funding Gap
Exascale Labs (XLAB) rose 12% in its Nasdaq debut, but a $12M cash balance against a $300M pipeline signals a funding gap for AI infrastructure growth.
Pasqal Soars 55% in Nasdaq Debut After $2B Quantum Merger
Pasqal shares jumped 54.7% to $15.14 on Nasdaq debut after $2B merger, while rivals IonQ, Rigetti, D-Wave, and Quantum Computing declined.